These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19860563)

  • 41. Investigation and management of an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak in an intensive care unit.
    Garlantézec R; Bourigault C; Boles JM; Prat G; Baron R; Tonnelier JM; Cosse M; Lefevre M; Jourdain S; Lelay G; Daniel L; Virmaux M; Le Du I; Tande D; Renault A; Lejeune B
    Med Mal Infect; 2011 Aug; 41(8):430-6. PubMed ID: 21640534
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems.
    Fernández-Cuenca F; Gómez-Sánchez M; Rodríguez-Baño J; Martínez-Martínez L; Vila J; Bou G; Pascual A
    Int J Antimicrob Agents; 2012 Sep; 40(3):235-8. PubMed ID: 22784855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.
    Liu WL; Liang HW; Lee MF; Lin HL; Lin YH; Chen CC; Chang PC; Lai CC; Chuang YC; Tang HJ
    PLoS One; 2014; 9(9):e107975. PubMed ID: 25255439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
    Park YK; Jung SI; Park KH; Kim SH; Ko KS
    Int J Antimicrob Agents; 2012 Jan; 39(1):81-5. PubMed ID: 21996405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
    Markogiannakis A; Fildisis G; Tsiplakou S; Ikonomidis A; Koutsoukou A; Pournaras S; Manolis EN; Baltopoulos G; Tsakris A
    Infect Control Hosp Epidemiol; 2008 May; 29(5):410-7. PubMed ID: 18419362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of multidrug-resistant clinical isolates of Acinetobacter baumannii : A 10-year analysis in a large tertiary care university hospital in central Europe with international admissions.
    Segagni Lusignani L; Starzengruber P; Dosch V; Assadian O; Presterl E; Diab-Elschahawi M
    Wien Klin Wochenschr; 2017 Nov; 129(21-22):816-822. PubMed ID: 28776101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
    Kopterides P; Koletsi PK; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2007 Nov; 30(5):409-14. PubMed ID: 17851052
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
    Prates CG; Martins AF; Superti SV; Lopes FS; Ramos F; Cantarelli VV; Zavascki AP
    Epidemiol Infect; 2011 Mar; 139(3):411-8. PubMed ID: 20513254
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran.
    Safari M; Saidijam M; Bahador A; Jafari R; Alikhani MY
    J Res Health Sci; 2013 Sep; 13(2):162-7. PubMed ID: 24077474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Jamal W; Salama M; Dehrab N; Al Hashem G; Shahin M; Rotimi VO
    J Hosp Infect; 2009 Jul; 72(3):234-42. PubMed ID: 19493588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
    Nutman A; Glick R; Temkin E; Hoshen M; Edgar R; Braun T; Carmeli Y
    Clin Microbiol Infect; 2014 Dec; 20(12):O1028-34. PubMed ID: 24930471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand.
    Kiddee A; Assawatheptawee K; Na-Udom A; Treebupachatsakul P; Wangteeraprasert A; Walsh TR; Niumsup PR
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital.
    Valencia R; Arroyo LA; Conde M; Aldana JM; Torres MJ; Fernández-Cuenca F; Garnacho-Montero J; Cisneros JM; Ortíz C; Pachón J; Aznar J
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):257-63. PubMed ID: 19199531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
    Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
    J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study.
    Jang TN; Lee SH; Huang CH; Lee CL; Chen WY
    J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
    Le Hello S; Falcot V; Lacassin F; Mikulski M; Baumann F
    Scand J Infect Dis; 2010 Dec; 42(11-12):821-6. PubMed ID: 20560868
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
    Saballs M; Pujol M; Tubau F; Peña C; Montero A; Domínguez MA; Gudiol F; Ariza J
    J Antimicrob Chemother; 2006 Sep; 58(3):697-700. PubMed ID: 16895941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii.
    Zhu LJ; Chen XY; Hou PF
    J Clin Lab Anal; 2019 Oct; 33(8):e22976. PubMed ID: 31318107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.